*Toxoplasma gondii* is a widespread obligate intracellular protozoan parasite causing toxoplasmosis, a potentially severe disease in immunocompromised or congenitally infected humans. Once it has invaded its hosting cell, the tachyzoite grows inside a parasitophorous vacuole (PV) in any type of nucleated cell, where it directs profound changes in the host cell transcriptome ([@bib33]; [@bib41]), which is known to tightly precede the host cell proteome ([@bib38]). In this regard, when the hosting cells are of mouse origin, IL-12 and IFN-γ were recognized as a pivotal immune axis contributing not only to the control of the tachyzoite population size ([@bib49]; [@bib35]; [@bib20]) but also to the *T. gondii* tachyzoite-bradyzoite developmental transition. Interestingly, once delivered within the host cell cytoplasm, lineage-specific polymorphic tachyzoite molecules have been shown to counteract this IL-12p70--IFN-γ axis, either acting directly---e.g., disruption of the autonomous host cell protecting immune processes ([@bib23])---or indirectly---e.g., subversion of the transcriptome machinery ([@bib24]). The majority of these tachyzoite molecules identified so far are transiently released early on during host cell invasion from the rhoptry secretory organelles ([@bib24]). Chief among them, the polymorphic rhoptry protein ROP16 directs tyrosine phosphorylation of STAT3 and STAT6 ([@bib46]; [@bib53]; [@bib7]). Once enclosed in the PV, additional effectors, including GRA15 ([@bib45]) and GRA16 ([@bib5]), are secreted from dense granules (DGs) and traffic to the host cell. Notably, GRA16 once exported beyond the PV membrane (PVM) reaches the host cell nucleus, where it positively modulates genes involved in cell cycle progression and the p53 tumor suppressor pathway ([@bib5]).

Considerable effort is currently being made to unravel the intricacy of the parasite and host interplay that leads, for the medically relevant type II and III strains, to the control of acute parasite multiplication and dissemination yet allows persistence of cryptic parasites in deep tissues. What is known is the need for a strong and persistent Th1 response and the correlated and marked proinflammatory cytokine IL-12 production by innate immune cells, including macrophages (MØ), CD8α^+^ dendritic cells, and neutrophils ([@bib49]; [@bib35]; [@bib20]). IL-12, in turn, activates natural killer and T cells to produce IFN-γ, which triggers parasite killing through the activation of IRGs (IFN-regulated GTPases; [@bib23]). In mice lacking IL-12 or IFN-γ, parasite expansion throughout the host is not controlled, causing host death ([@bib18]; [@bib48]; [@bib54]). Although IFN-γ is the main mediator of resistance to *Toxoplasma* infection, IL-12 synthesis appears as the key cytokine to be tightly regulated in a strain-specific manner by *Toxoplasma*. In this regard, macrophages are classically (or M1) activated by a type II strain while they are alternatively (or M2) activated by hypervirulent type I and avirulent type III strains ([@bib26]). While GRA15 type II allele contributes to M1 activation by activating NF-κB and downstream proinflammatory cytokines, in particular IL-12p70 ([@bib26]; [@bib45]), ROP16 triggers a STAT3/6-dependent M2 response that prevents IL-12p70 from being synthesized ([@bib46]; [@bib7]; [@bib26]).

Sustained IL-12p70 production in tissues hosting *T. gondii* is not exclusively controlled by NF-κB but could also require the MAPK pathways ([@bib29]; [@bib34]). MAPK pathways encompass a series of kinases that activate each other through an orchestrated cascade (MAP4K, then MAP3K, then MAP2K) that ends with the phosphorylation of a specific MAPK that positively or negatively regulates the expression of suites of genes by activating effector proteins, in particular transcription factors. A wide range of stimuli activates MAPKs, including inflammatory cytokines, osmotic stress, LPS, growth factors, osmotic shock, and UV light ([@bib31]; [@bib10]). Although it has been proposed that *Toxoplasma* bypasses the MKK-dependent MAPK phosphorylation cascade to induce autophosphorylation of the p38α MAPK and to promote IL-12p70 production ([@bib29]), the tachyzoite molecule subverting the host p38α MAPK pathway remains unknown.

Within this context, we characterize a novel DG-like protein, hereafter referred to as GRA24, that is exported beyond the PV to the host cell nucleus. We discovered that GRA24 directly interacts with p38α, leading to an unusually persistent autophosphorylation and activation of the host kinase. 3D modeling of the complex predicts unusual structural features of the complex that highlight a novel pathway for p38α extended activation. The GRA24-dependent p38α activation was documented in both human stromal cells and mouse macrophages, the latter up-regulating the expression of multiple proinflammatory cytokines (i.e., IL-12p40 and MCP-1/CCL2) in a strain-specific manner. Our results demonstrate a substantial role for GRA24 in the control of parasite burden in the gut of infected mice. Finally, as a link between the cytokine response and GRA24-p38α activation, we identified several transcription factors up-regulated in a GRA24-dependent fashion, among which are Egr-1 and c-Fos. Collectively, our findings identify a GRA24-dependent sustained p38α kinase activation pathway that could contribute shaping and modulating immune response---at least the one driven by the *T. gondii* tachyzoite developmental stage.

RESULTS
=======

GRA24 is a novel DG-like protein exported to the host cell nucleus
------------------------------------------------------------------

The gene *TGME49_030180* encoding GRA24 was originally identified in silico together with *GRA16* ([@bib5]) as strong parasite candidate genes with attributes to both target the parasite secretory pathway and to reach the nuclei of *T. gondii* tachyzoite-hosting cells. *GRA24* encodes a 542-aa protein with a predicted N-terminal signal peptide, an internal putative bipartite nuclear localization sequence, and two repeats, R1 and R2, at the C-terminal end ([Fig. 1 A](#fig1){ref-type="fig"}). GRA24 protein is unique because it has no significant homology with any proteins, not even with the close relative *Neospora caninum* proteins. In *Toxoplasma*, GRA24 harbors significant polymorphism between the allele shared by types II and III clonal lineages and the allele typifying type I clonal lineage ([Fig. 1 B](#fig1){ref-type="fig"}). In fibroblasts hosting tachyzoites expressing a carboxy-terminal HAFlag-tagged version of GRA24, the protein is distinctly detected in the host cell nucleoplasm at 16 h after invasion and later, whereas there is no detectable protein left in the intracellular tachyzoites ([Fig. 2 A](#fig2){ref-type="fig"}). In contrast, in free tachyzoites, GRA24-HAFlag delineates punctuate structures throughout the parasite cytoplasm which occasionally overlap with the canonical DG proteins GRA1 and GRA7 ([Fig. 2, D and E](#fig2){ref-type="fig"}) while being excluded from the two typical apical secretory organelles using toxofilin and MIC2 as markers for rhoptry and microneme, respectively ([Fig. 2, B and C](#fig2){ref-type="fig"}). Interestingly, when overexpressed under the strong constitutive GRA1 promoter, a significant fraction of GRA24 is seen in the PV space similarly to GRA1, thus suggesting that GRA24 export across the PVM is a limiting step ([Fig. 2, F and G](#fig2){ref-type="fig"}). We concluded from these data that GRA24 is a novel DG-like protein that crosses the PVM of maturing vacuoles to reach the host cell nucleus, thereby belonging to the recently defined GRA exported protein subfamily typified by GRA16 ([@bib5]).

![**The gene *GRA24* generates splice variants encoding two distinct proteins.** (A) Schematic representation of the *GRA24* alternative splice variants and their corresponding GRA24 protein isoforms. The putative signal peptide is shown in yellow (the cleavage site is predicted by SignalP). A putative nuclear localization signal is in green (as predicted by PSORT). The KIM/D-motif (in red square) and the internal repeats (colored in red) are shown. (B) GRA24 amino acid alignment. The predicted amino acid sequence for the primary translation product of the *GRA24* gene is shown for type I (*TGGT1_117710*), II (*TGME49_030180*), and III (*TGVEG_025320*) parasites. Single amino acid polymorphisms are indicated for type II and III (in blue) versus type I (in red). The alignment was done by ClustalW2 (EMBL-EBI).](JEM_20130103_Fig1){#fig1}

![**GRA24 is a novel DG protein exported beyond the PV into the host cell nucleus.** (A) Time course of GRA24 secretion and export to the host cell nucleus. Human fibroblasts (HFF) were infected with parasites expressing an HAFlag (HF)-tagged copy of *GRA24* (RH*ku80 GRA24*-*HF*), fixed, and stained with anti-HA antibodies (red). Images are representative of at least four experiments. Bar, 20 µm. (B) GRA24-HAFlag is contained in cytoplasmic organelles distinct from the apical micronemes and rhoptries and partially colocalizing with DG proteins. (B--E) Free parasites were fixed, permeabilized, and successively stained with antibodies raised against HA to label GRA24 (green) and then with antibodies (red) against the micronemal protein MIC2 (B), the rhoptry protein toxofilin (C), and the DG proteins GRA7 (D) and GRA1 (E). The top panels show the DIC images corresponding to the IFA (bottom panels), and the right frames show 3D images processed using MetaMorph and Imaris software. Images are representative of at least two experiments. Bars, 5 µm. (F) IFA of GRA24-HF expressed by the strong promoter of GRA1. HFF monolayers were infected with RH*ku80* parasites expressing ectopically pGRA1-GRA24-HF. 18 h after infection, cells were fixed and secretion of GRA24 was monitored using anti-HA antibodies (green). Images are representative of at least two experiments. Bar, 10 µm. (G) Higher magnification of a vacuole showing GRA24-HF signal in the vacuolar space. Bar, 2.5 µm.](JEM_20130103_Fig2){#fig2}

GRA24 forms a stable dimeric complex with host p38α kinase
----------------------------------------------------------

Because GRA24 operates as a secreted DG that crosses the PVM and traffics to the host cell nucleus, we next sought partners of GRA24 by applying chromatography and ion-trap mass spectrometry to nuclear extracts that were prepared from inducible GRA24-HAFlag--expressing 293 cell lines. After induction, the protein localizes in the nucleus ([Fig. 3 A](#fig3){ref-type="fig"}), and regardless of the tag position (N- or C-terminal fusion), GRA24 is embedded in a remarkably robust molecular mass complex (400 kD, fractions 22--28; [Fig. 3, B and E](#fig3){ref-type="fig"}), which contains the CSBP2/SAPK2α isoform, also named p38α, as the only GRA24 relevant partner ([Fig. 3 C](#fig3){ref-type="fig"}). Western blotting confirmed the partnership between GRA24 and p38α ([Fig. 3, B and E](#fig3){ref-type="fig"}). The GRA24--p38α complex was also isolated from primary human foreskin fibroblasts (HFFs) and mouse J774 MØ line hosting GRA24-HAFlag--expressing tachyzoites, demonstrating that the complex forms not only in stromal cells but also in macrophages hosting cell-cycling tachyzoites ([Fig. 3 D](#fig3){ref-type="fig"}). Using the dual phosphorylation of Thr180/Tyr182 as a hallmark of p38 activation ([@bib9]), we confirmed by immunoblotting that p38α in complex with GRA24 is activated (i.e., phospho Thr180/Tyr182 positive) when purified from inducible GRA24-HAFlag--expressing 293 cells ([Fig. 3, B and E](#fig3){ref-type="fig"}) or from infected murine and human cells ([Fig. 3 D](#fig3){ref-type="fig"}).

![**GRA24 forms a dimeric complex with the p38α MAPK.** (A) Immunofluorescence analysis (IFA) of GRA24-HAFlag ectopically and stably expressed in 293-TRex cell line. Cells were either left untreated (−) or treated with 1 µg/ml tetracycline for 20 h before fixation and staining with anti-HA antibodies (red) and Hoechst DNA-specific dye (blue). Bar, 2.5 µm. (B) GRA24-associated polypeptides were purified from nuclear extracts of 293-TRex cells tetracycline-induced to express GRA24-HF. Size exclusion chromatography (SEC) of GRA24-containing complexes after Flag affinity selection. Fractions were analyzed by silver staining and immunoblotting to detect GRA24-HF (anti-HA), total p38α, and Thr180/Tyr182 phosphorylated \*P-p38α. Data are representative of two experiments. (C) Mass spectrometry analysis of SEC fraction 22. Identity of the proteins with their respective number of peptides is indicated on the right. (D) GRA24-p38α association detected in HFF and J774 MØ infected by RHku80 GRA24-HF (18 h). Tagged proteins were Flag-immunoprecipitated from extracts and eluates were analyzed by immunoblotting. Data are representative of two experiments. (E) GRA24-associated polypeptides were purified from nuclear extracts of 293-TRex cells induced to express an N-terminal HAFlag-tagged GRA24. SEC Fractions were analyzed by immunoblotting to detect HAFlag-GRA24 (anti-HA), total p38α, and Thr180/Tyr182 phosphorylated \*P-p38α. Data are representative of two experiments.](JEM_20130103_Fig3){#fig3}

Deletion of *GRA24* is sufficient to abolish host cell p38α activation by *Toxoplasma*
--------------------------------------------------------------------------------------

To investigate the role of GRA24 on host cell p38α activation during infection, WT, *GRA24* knockout, or complemented tachyzoites were generated. The *GRA24* gene was disrupted by homologous recombination (Δ*gra24*) in both type I (RH*ku80*) and type II (Pru*ku80*) strains while the mutant was complemented with a single copy of a *GRA24* functional allele driven by its endogenous promoter ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20130103/DC1){#supp1} and [Table S1](http://www.jem.org/cgi/content/full/jem.20130103/DC1){#supp2}). All strains behave similarly in vitro, indicating that *GRA24* is not essential for either invasion or intracellular survival (unpublished data). Consistent with our previous data, no phospho-p38α population is ever detected in HFF and J774 MØ cells hosting *GRA24* knockout tachyzoites in contrast to cells hosting *GRA24* WT virulent type I or cystogenic type II parasite strains ([Fig. 4, A and B](#fig4){ref-type="fig"}). Importantly, reintroduction of the *GRA24* gene in the mutant restores a parasite's ability to induce p38α phosphorylation ([Fig. 4, C and D](#fig4){ref-type="fig"}), whereas p38α was never found to be activated by *Neospora caninum* regardless of the multiplicity of infection (MOI) or the duration of infection ([Fig. 4, C and D](#fig4){ref-type="fig"}). Remarkably, although p38α activation usually occurs transiently and within minutes in response to most stimuli ([@bib14]), GRA24-dependent p38α phosphorylation is, in contrast, impressively sustained as late as 24 h after the swift tachyzoite invasion step ([Fig. 4](#fig4){ref-type="fig"}), a trait which fits well with the unusual long-lasting presence of GRA24 into the host cell ([Fig. 2 A](#fig2){ref-type="fig"}) and suggests a direct control on the p38α kinase activity.

![**GRA24 elicits phosphorylation and relocation of host p38α in the nucleus.** (A and B) Immunoblotting detection of \*P-p38α and p38α in HFF (A) and J774 MØ (B) uninfected (u.i.) or infected (24 h) with RH*ku80*, RH*ku80 Δgra24*, Pru*ku80*, and Pru*ku80 Δgra24* strains. Cytosolic (C) and nuclear (N) cell lysates were probed with the indicated antibodies. Histone H4 acetylated (K5-K8-K12-K16) (nuclear), TBP (host-specific), and TgHDAC3 (parasite-specific) levels are shown as loading controls. (C) Subcellular in situ detection of \*P-p38α (green) in HFF uninfected (u.i.) or infected (24 h) with RH*ku80*, RH*ku80 Δgra24*, RH*ku80 Δgra24*, *GRA24*^+^, and *Neospora caninum* strains. Data are representative of at least three experiments. Bars, 10 µm. (D) Immunoblotting detection of \*P-p38α, \*P-Ser133-CREB, and \*P-Thr71-ATF2 in nuclear fraction and Toxofilin (parasite-specific) in cytosolic fraction from HFF uninfected (u.i.) or infected (24 h) with the aforementioned strains and *Neospora caninum*. Data are representative of two experiments.](JEM_20130103_Fig4){#fig4}

Once present in the hosting cell, GRA24 allows sustained p38α autophosphorylation, independently of the prototypic kinase cascade
---------------------------------------------------------------------------------------------------------------------------------

The prototypic p38α activation is achieved by upstream MAPK kinase (MKK3/6; [@bib2]) or, alternatively, through TAB1-mediated p38α autophosphorylation ([@bib19]). Another pathway, restricted so far to T cells upon T cell receptor activation, includes phosphorylation of Tyr323 by the ZAP-70 tyrosine kinase that leads to p38 autophosphorylation but solely on Thr180 ([@bib47]). The host p38α autophosphorylation, observed when tachyzoites are nested in their PV, was proposed to reflect a TAB1-dependent mechanism, thus a mechanism bypassing the MKK-dependent MAPK phosphorylation ([@bib29]). In *T. gondii*--hosting J774 MØ cells exposed to SB203580, a competitive inhibitor of ATP binding blocking p38α autophosphorylation but not trans-phosphorylation by MKKs ([@bib21]), there is a complete abrogation of GRA24-induced p38α phosphorylation, a phenotype which was not observed when cells were treated with PD98059 and SP600125, which have been shown to block the MEK1/2 and the JNK pathways, respectively ([Fig. 5, A and B](#fig5){ref-type="fig"}). In addition, expression of GRA24 is sufficient to trigger p38α autophosphorylation because SB203580 inhibits p38α activation in 293 cells induced for GRA24 synthesis, whereas MEK1/2 and JNK inhibitors do not ([Fig. 5, C and D](#fig5){ref-type="fig"}). GRA24 is the first molecular switch originating from a eukaryotic parasite that directly activates p38α in a sustained way independently of the prototypic kinase cascade in both human stromal cells and mouse macrophages.

![**GRA24 promotes p38α autophosphorylation.** (A) Diagram showing the enzymes and their respective inhibitor. (B) Specific pharmacological inhibition of GRA24-dependent p38α phosphorylation in J774 MØ. Cells were incubated for 1 h with p38 (SB203580, 15 µM), SAPK/JNK (SP600125, 25 µM), and MKK (PD98059, 15 µM) inhibitors or DMSO vehicle before infection in presence of the drug with RH*ku80* and RH*ku80 Δgra24* strains (18 h). Nuclear fractions were immunoblotted with the indicated antibodies. Data are representative of two experiments. (C) In situ \*P-p38α (green) detection in 293-TRex cells before (−Tet) or after (+Tet) conditional GRA24-HF expression (18 h; red). SB203580 impedes p38α phosphorylation. Images are representative of at least three experiments. Bar, 2.5 µm. (D) p38α phosphorylation status in 293-TRex cells pretreated by inhibitors (see B) and induced (+Tet) or not (−Tet) to express GRA24-HF. Nuclear fractions were immunoblotted with the indicated antibodies. Data are representative of two experiments.](JEM_20130103_Fig5){#fig5}

GRA24 interacts with p38α through a singular kinase interacting motif (KIM)
---------------------------------------------------------------------------

To detail further how GRA24 binding to p38α promotes activation of the kinase, we mapped the GRA24 region interacting with the enzyme. To this end, HAFlag epitope-tagged carboxy-terminal truncated forms of GRA24 were stably expressed in RH*ku80* parasites ([Fig. 6 A](#fig6){ref-type="fig"}). The two chimeric proteins, namely GRA24 ΔR2 and GRA24 ΔR1/R2, migrate at their expected molecular weights ([Fig. 6 C](#fig6){ref-type="fig"}) and localize in the host cell nuclei after infection ([Fig. 6, B and C](#fig6){ref-type="fig"}), thereby indicating that the removed domains do not affect the export and the transit into the host cell of the chimeric proteins. However, although deleting only repeat R2 has no effect on p38α binding and activation, double deletion of R1 and R2 abolishes GRA24 binding property to p38α ([Fig. 6 C](#fig6){ref-type="fig"}), preventing any p38α phosphorylation ([Fig. 6 B](#fig6){ref-type="fig"}), thus pointing to the required contribution of GRA24 R1 domain to p38α activation. These observations prompted us to look for the molecular determinants within the repeat that drive the interaction with/activation of p38α. We identified a perfect replicate of the canonical KIM (also known as D motif, [Fig. 6 D](#fig6){ref-type="fig"}) defined as a key MAPK-interacting structural element that, in addition, provides specificity toward the MAP kinase partners ([@bib43]; [@bib16]). The motif is typified by a cluster of basic residues at the N terminus and hydrophobic amino acids near the C terminus ([Fig. 6 D](#fig6){ref-type="fig"}). The GRA24-KIM clearly belongs to the tyrosine phosphatase PTP-KIM class (defined in [@bib17]; [Fig. 6 D](#fig6){ref-type="fig"}) but displays an unusual insertion of a proline (Pro-451) between hydrophobic canonical residues ϕL and ϕA that, in tandem with Pro-452, confers local rigidity to the linear peptide embedded in the KIM binding site ([Fig. 6 D](#fig6){ref-type="fig"}) and, most likely, adds specificity toward p38α ([@bib17]). Our docking models validate the proper binding of GRA24-KIMs to p38α ([Fig. 7](#fig7){ref-type="fig"}). More specifically, the two N-terminal arginine residues (Arg-444 and Arg-445) share salt bridges with CD-site Asp-316 and Glu-81 of p38α, whereas both Leu-450 (ϕL) and Leu-453 (ϕA) insert optimally into the shallow hydrophobic pockets ([Fig. 7, A and B](#fig7){ref-type="fig"}). Finally, Ile-455 (ϕB) reinforces the hydrophobic interactions between the two partners, as previously reported for the He-PTP Val-31 residue (ϕB; [@bib16]). Collectively, peculiar GRA24-KIM structural features empower GRA24 ability to bind to p38α, thereby accounting for the remarkable resistance to the highly stringent conditions used during the GRA24--p38α complex purification ([Fig. 3, B and E](#fig3){ref-type="fig"}). Such binding properties are expected to potentiate p38α autophosphorylation, as KIM-mediated interaction with p38α has been shown to trigger local ([Fig. 7 E](#fig7){ref-type="fig"}) as well as long-range conformational changes, in particular within the activation loop that becomes disordered, therefore exposing the phosphorylatable Thr-180 and Tyr-182 residues ([@bib8]; [@bib56]; [@bib55]). Of note, the KIM repeat itself, i.e., within R1 and R2 ([Fig. 6 A](#fig6){ref-type="fig"}), might favor p38α trans-autophosphorylation via the simultaneous binding of two p38α monomers ([@bib11]).

![**A singular KIM motif in GRA24 repeats is required for p38α autophosphorylation.** (A) Diagram of GRA24 C-terminal truncations. Signal peptide (yellow), nuclear localization signal (green), internal repeats (red), and KIM (red square) sequences are shown. (B) IFA of GRA24 chimeric proteins (red), subcellular localization, and p38α phosphorylation status (green) in HFF infected with parasites expressing HF-tagged GRA24 full-length or truncates (see A). Data are representative of three experiments. Bars, 20 µm. (C) J774 MØ were infected (24 h) with parasites expressing HF-tagged GRA24 full-length or truncates. Tagged proteins were Flag-immunoprecipitated and eluates were analyzed by immunoblotting. Data are representative of two experiments. (D) Sequence alignment of KIMs from GRA24 and phosphatases. The N-terminal hydrophobic residue (φH), positively charged residues (basic), and φL-X-φA-X-φB motif are indicated.](JEM_20130103_Fig6){#fig6}

![**Structural features of the GRA24-KIM1 peptide main chain docked into p38α.** (A and B) GRA24-KIM1 peptide docked into p38α (1LEW). The N-terminal side binds to the charged CD site while C-terminal hydrophobic residues insert into hydrophobic pockets ϕL, ϕA, and ϕB. The hydrophobic pocket is formed by the loop between β7 and β8 and the loop joining αD and αE helices. (C and D) GRA24-KIM1 peptide docked and energy minimized (see Materials and methods) into p38 KIM-binding domain. (C) Hydrogen bond network of the two arginines at the CD domain. (D) Peptide hydrophobic C terminus flanked by loops 159--163 and 118--125. (E) Cα-backbone KIM binding site area superposition of p38α, ERK2, and JNK models demonstrating local displacement upon binding. p38α peptides (MEF2A-1lew and MKK3b-1lez green), ERK2 peptides (MKP3-2fys and HePTP-2gph, blue), and JNK (pepJIP1-1ukh, purple) and p38α-GRA24/KIM1 docked peptide (light blue) are shown.](JEM_20130103_Fig7){#fig7}

GRA24 activates the expression of proinflammatory genes in macrophages
----------------------------------------------------------------------

The unique features of the unraveled interaction between GRA24 and p38α and the consequences on p38α activation status prompted us to analyze whether the GRA24--p38α complex contributes to the typical changes in gene expression observed in either stromal or phagocytic cells infected with tachyzoites ([@bib3]; [@bib46]; [@bib26]). To address this possibility, we performed a genome-wide expression profiling of mouse BM-derived macrophages (BMDMs) hosting parental versus Δ*gra24* parasites from both type I and type II strains ([Fig. 8 A](#fig8){ref-type="fig"}). We focused our analysis on genes that were altered with more than a twofold change when comparing each Δ*gra24* mutant with their respective parental strains. KEGG analysis highlights 10 pathways as significantly and selectively induced (P \< 0.05) in a GRA24-dependent fashion, a majority of which regulates proinflammatory cytokines (e.g., *IL-6*, *IL-12b*, and *TNF*) and chemokines (e.g., *MCP-1*, *CCL5*, *CXCL1*, and *CXCL10*) known to operate in any sterile tissues colonized by invasive microbes, whether they are nonparasitic or parasitic ([Fig. 8 C](#fig8){ref-type="fig"}). Interestingly, the GRA24-dependent changes are exacerbated in cells infected with the type II clonal lineage, possibly as a consequence of allelic polymorphism between the strain types ([Fig. 1 B](#fig1){ref-type="fig"}), which leads to a concomitant up-regulation of 13 genes linked to M1-MØ activation and down-regulation of 17 genes associated with the alternative M2--MØ pathway ([Fig. 8 B](#fig8){ref-type="fig"}). We have also noticed that both IFN-γ-- and iNOS-coding transcript populations were also up-regulated in a GRA24-dependent manner by 12- and 3-fold, respectively ([Fig. 8, A and B](#fig8){ref-type="fig"}). Of note, at least within the time frame (24 h) examined in these experiments, the BMDM supernatants display no difference in IFN-γ levels as assessed by ELISA (unpublished data).

![**GRA24 alters the host-cell transcriptome.** C57BL/6 BMDMs were infected with either type I RH*ku80* Δ*gra24* or type II Pru*ku80* Δ*gra24* mutant parasites and compared with infection with their respective parental *Toxoplasma* strains. Cells were infected at an MOI of 1:3 and total RNAs were extracted 18--20 h after infection. cDNA synthesis, labeling, and differential gene expression analysis are detailed in Materials and methods. The differentially regulated genes were identified after normalization of the raw data and filtering genes with a fold change cutoff of twofold or more and p-value ≤0.05. (A) Heat map of the GRA24-regulated cytokine-related genes identified by KEGG analysis. Mean log~2~ gene expression values were median-centered and genes were clustered according to the biological pathways identified. The complete set of genes is listed in GEO dataset accession no. [GSE38782](GSE38782). (B) Heat map representation of the GRA24-regulated genes associated with classical (M1) or alternative (M2) MØ phenotypes after infection of BMDM with type II strains. Gene symbols and the fold change (FC, at least twofold mean difference) in gene expression are listed for GRA24II-dependent genes for comparison with those reported by [@bib26] as ROP16I- and GRA15II-regulated. (C) KEGG analysis of the differentially expressed genes when comparing WT versus Δ*gra24*-infected cells. Genes listed in GEO dataset accession no. [GSE38782](GSE38782) (fold change cutoff twofold or more) were analyzed to determine pathways that were statistically overrepresented (p-value \<0.05).](JEM_20130103_Fig8){#fig8}

GRA24-dependent IL-12p40 and MCP-1 production by mouse macrophages hosting tachyzoites
--------------------------------------------------------------------------------------

As stated above, in laboratory mice, the *T. gondii*-- and mouse-driven generation of immune type 1 effectors that prevent both uncontrolled tachyzoite population expansion and subsequent host death is characterized by the IL-12p40 production by tachyzoites-hosting macrophages ([@bib48]; [@bib49]; [@bib54]). GRA24 is clearly playing a major role in regulating IL-12p40 synthesis, as its loss severely compromises both IL-12 mRNA and protein levels in mouse BMDM ([Fig. 8 B](#fig8){ref-type="fig"} and [Fig. 9 A](#fig9){ref-type="fig"}). Similarly, on day 4 after infection, mice infected with a Pru*ku80* Δ*gra24* strain had significantly less IL-12p40 in their i.p. cavities and serum than mice infected with the parental strain ([Fig. 9 B](#fig9){ref-type="fig"}). However, despite an efficient GRA24-mediated p38α activation ([Fig. 4](#fig4){ref-type="fig"}), type I parasites fail to trigger IL-12 secretion in BMDM ([Fig. 8 A](#fig8){ref-type="fig"} and not depicted), a phenotype which might reflect a dominant IL-12 suppressive activity driven by the *ROP16* type I allele ([@bib46]; [@bib53]; [@bib7]). In addition, other effectors, such as GRA15, are involved in the control of IL-12 synthesis through the activation of the NF-κB pathway ([@bib45]). Although GRA15 does not trigger p38α phosphorylation ([Fig. 9 C](#fig9){ref-type="fig"}), GRA24 does not affect NF-κB (not depicted), highlighting that several *T. gondii* strain-specific or -shared effectors display synergistic or antagonist effects on the regulation of IL-12p40--coding gene expression. In support of GRA24 key contribution to the IL-12 response, GRA24 is found to critically account for the typical increase in MCP-1, CXCL1, CCL5, and CXCL10 chemokine synthesis ([Fig. 9 D](#fig9){ref-type="fig"}) triggered by a type II tachyzoite lineage. Remarkably, MCP-1 was shown to play a substantial role in the recruitment, to *T. gondii*--loaded tissues, of Gr-1^+^ inflammatory monocytes that, in turn, produce nitric oxide and are essential for the local control of the tachyzoite population size ([@bib44]; [@bib12]). The above results argue that the GRA24-dependent MCP-1 secretion might be involved in the recruitment of Gr-1^+^ monocytes in tissues transiently remodeled as cell-cycling tachyzoite-protective niches. To examine the functional consequences in vivo of GRA24-dependent MCP-1 secretion, we challenged C57BL/6 mice with 10^3^ tachyzoites of Pru*ku80* WT or Pru*ku80* Δ*gra24* strains and assessed parasite numbers in the peritoneal exudate as well as in the spleen. A larger number of parasites are detected beyond day 7 in the peritoneal contents of mice infected with Pru*ku80* Δ*gra24* than in mice infected with the parental strain ([Fig. 9 E](#fig9){ref-type="fig"}). Parasites are also found in the spleen, indicating that the infection becomes quickly systemic, but in this tissue no significant deviation in parasite loads was detected between the WT and the Δ*gra24* strains at any of the time points analyzed ([Fig. 9 E](#fig9){ref-type="fig"}). These results suggest that the deletion of *GRA24*, while suppressing MCP-1 production, most likely prevents Gr-1^+^ recruitment and contributes to impair the ability of the mice to suppress parasite numbers at the site of infection in the gut. We then assess if GRA24 is altering the overall host survival of C57BL/6 mice. A dose of 5 × 10^2^ tachyzoites required to achieve a near LD~100~ when using the Pru*ku80* strain was i.p. inoculated to C57BL/6 mice whose survival was monitored over the acute phase of infection. Mice infected by either the WT Pru*ku80* or Pru*ku80* Δ*gra24* parasites succumb to infection within 10 to 20 d (unpublished data; *n* = 6 mice per strain). Therefore, *GRA24*-deficient parasites did not fully recapitulate the phenotype of MCP-1^−/−^ and CCR2^−/−^ mice that were shown to be profoundly susceptible to acute toxoplasmosis ([@bib44]; [@bib12]). This difference might be a result of the genetic background of the parasite strains, the type II Pru*ku80* strain ([@bib15]) being more virulent and less cystogenic than the type II ME49 strain used in most *Toxoplasma* infection including those using MCP-1^−/−^ and CCR2^−/−^ mice ([@bib44]).

![**GRA24 promotes chemokine secretion and contributes to the control of early parasite replication in vivo at the site of infection.** (A) IL-12p40 cytokine production by uninfected (u.i.) or 24-h-infected (Pru*ku80 Δgra24* or parental strains) BMDM measured using ELISA. Means of three independent experiments ± SD are shown (\*, P \< 0.005, two sample Student's *t* tests). (B) Peritoneal lavage fluid and serum were collected on days 2 and 4 after infection of C57BL/6 mice that had received an i.p. dose of 10^3^ Pru*ku80* WT or Pru*ku80* Δ*gra24* tachyzoites. Concentrations of IL-12p40 were determined by ELISA. Data shown are means ± SD with *n* = 3 individual mice per parasite genotype at each time point. Error bars represent SD from one experiment. \*: significantly different from WT (P \< 0.05, Student's *t* test). (C) Subcellular detection in J774 infected with *Δgra24* and *Δgra15* mutants demonstrated that \*P-p38α and Egr-1 induction is dependent of GRA24 and independent of GRA15. Data are representative of two experiments. (D) Comparison of GRA24-dependent and -independent chemokine expression profiles after BMDM infection by *Toxoplasma*. Quantification is given in digital light units (DLU) drawn from the whole chemokine array. Error bars represent SD (two sample Student's *t* tests; \*, P \< 0.006). (E) WT C57BL/6 mice were i.p. infected with a dose of 10^3^ Pru*ku80* WT or Pru*ku80* Δ*gra24* tachyzoites. Parasites were enumerated using recovered i.p. contents or from homogenates of spleen at the indicated times after infection. Data shown are means ± SD (from three mice per parasite genotype) and representative of two independent experiments. \*: significantly different from WT (P \< 0.05, Student's *t* test).](JEM_20130103_Fig9){#fig9}

GRA24--p38a complex regulates the expression of Egr-1 and c-Fos transcription factors
-------------------------------------------------------------------------------------

Finally, as a link between the cytokine response and the direct GRA24-dependent p38α activation, we identified several transcription factors up-regulated in a GRA24-dependent fashion in MØ, among which those that either control the immediate early gene response or are immediate early prototype gene products like Egr-1 and c-Fos ([Fig. 10 A](#fig10){ref-type="fig"}). Of note, first, *Egr-1* and c-*Fos* belong to a restricted set of 30 core genes whose expression is equally regulated by major p38α MAPK-activating stimuli (i.e., osmo-stress, the cytokine TNF, and the protein synthesis inhibitor anisomycin; [@bib14]), and second, the *Egr-1* promoter activity is blocked by a pharmacologically inactivated p38α kinase ([@bib51]). These observations strongly argue for a direct function of GRA24 on classical p38α MAPK-regulated genes and confirm previous studies on the induction of *Egr-1* and its paralog *Egr-2* during *Toxoplasma* infection ([@bib40]; [@bib52]). By Western blotting and immunofluorescence, we indeed confirmed at the protein level that Egr-1 is induced in the nuclei of human stromal cells and mouse macrophages hosting WT *T. gondii*, a phenotype which is not induced in cells hosting Δ*gra24 Toxoplasma* or *Neospora* ([Fig. 10, B and C](#fig10){ref-type="fig"}; and not depicted). Reintroduction of the *GRA24* gene restored the *Toxoplasma* ability to up-regulate Egr-1 ([Fig. 10 B](#fig10){ref-type="fig"}). Egr-1 induction was also validated in 293 cells conditionally expressing GRA24 ([Fig. 10 D](#fig10){ref-type="fig"}), and the level of expression was reduced in a dose-dependent fashion by the inhibitor SB203580, thereby establishing the link between Egr-1 and the autophosphorylation of p38α by GRA24 ([Fig. 5 B](#fig5){ref-type="fig"}). Finally, we identified the GRA24-KIM as the basis of p38α binding and autophosphorylation that further entails Egr-1 activation ([Fig. 6 B](#fig6){ref-type="fig"}). Besides Egr-1, *c-fos* is also regulated at the transcriptional level by GRA24 ([Fig. 10 A](#fig10){ref-type="fig"}). In particular, this transcription factor is phosphorylated on serine 32 in a GRA24-dependent fashion in both murine MØ and human fibroblasts ([Fig. 10 E](#fig10){ref-type="fig"} and not depicted). Unexpectedly, *Toxoplasma* elicits a prolonged induction of Egr-1 and c-Fos, which correlates with the nuclear persistence of the GRA24--p38α complex during infection but differs from the transient usual canonical activation of these genes. The induction of these transcription factors by GRA24 is most likely followed by a second wave of host cell transcriptome alteration because both Egr-1 and c-Fos then operate in a hierarchical manner by inducing the expression of their downstream genes (e.g., Egr-1-regulated genes, see GEO accession no. [GSE38782](GSE38782)).

![**GRA24 triggers up-regulated expression of the host transcription factors Egr-1 and c-FOS.** (A) Heatmap representation of host transcription factors up-regulated in a GRA24-dependent fashion in BMDM infected by the aforementioned strains. Egr-1 and c-FOS are indicated in red. (B) IFA of GRA24-dependent induction of Egr-1 (red) in uninfected (u.i.) or infected (24 h) HFF by the indicated strains. Images are representative of at least four experiments. Bar, 20 µm. (C) Cellular fractionation of J774 cells left uninfected (u.i.) or infected (24 h) by the indicated strains. Cytoplasmic (C) and nuclear (N) fractions were analyzed by Western blotting using indicated antibodies. TBP (host-specific) and toxofilin (parasite-specific) are shown as loading controls. Data are representative of three experiments. (D) Western blot analysis of nuclear fractions of 293-TRex cell line expressing GRA24-HF using indicated antibodies. Cells were either left untreated (− Tet) or treated (+ Tet) with 1 µg/ml tetracycline for 20 h. AcH4 was used to assess host nuclear protein enrichment. Data are representative of three experiments. (E) IFA showing the serine 32 phosphorylation status of c-FOS (in red) in serum-starved confluent HFF left uninfected (u.i.) or after 24 h of infection by RH*ku80*, RH*ku80* Δ*gra24*, and RH*ku80* Δg*ra24*, *GRA24*^+^ parasites. Images are representative of two experiments. Bar, 20 µm.](JEM_20130103_Fig10){#fig10}

DISCUSSION
==========

Host cell invasion is a critical step by which *Toxoplasma* zoites rapidly establish themselves and further complete their developmental program as bradyzoite-containing cysts known to be located in the tissue of prey that are ingested by predators. Recent research has highlighted that early during the invasion process, the parasite secretes several rhoptry bulb resident proteins with a majority of kinases and phosphatases that co-opt host cells by interfacing with their signaling pathways ([@bib36]). Once internalized, a *Toxoplasma* tachyzoite resides within a dynamic PV that is constantly reshaped through molecular exchanges with the host cell cytoplasm and that support parasite growth. Although nonenzymatic molecules secreted by DG were first thought of as parasite effectors restricted to the PV biogenesis and maturation, a recent study ([@bib5]) and the present study highlight that DG-resident nonenzymatic proteins are secreted into the vacuole space, cross the PVM, and reach the host cell nucleus where they modulate host gene expression. Thus, GRA16 and GRA24 emerge as a subfamily of DG-scaffolding proteins exported beyond the tachyzoite-hosting vacuole to operate as effector molecules in infected cells.

In the present study, we have identified GRA24 as a strong interactor of host p38α, with the resulting complex acting as a regulator of gene expression in the host cell nucleus. Indeed, we establish that GRA24 interacts with the p38α enzyme, triggers its autophosphorylation, and consequently its activation. GRA24 bypasses the typical MKK-dependent MAPK phosphorylation cascade upstream of p38 and is the first parasitic microbe agonist so far described to promote p38α autophosphorylation through a dimeric stable complex. Interestingly, GRA24 specifically promotes Thr180 autophosphorylation of p38α because it neither activates ERK1,2 (Thr202/Tyr204 and Thr185/Tyr187, respectively) nor alters the JNK (Thr183/Tyr185) phosphorylation (unpublished data). In agreement with these results, none of the aforementioned kinases copurify with GRA24, reinforcing the notion of a high specificity of GRA24 function on p38α. Another unique feature of GRA24 function lies in its property to promote a sustained phosphorylation of p38α that correlates with the long-lasting secretion of GRA24. This kinetics of activation is remarkably distinct from the transient activation mediated by the prototypic MAPK pathway and has important consequences because it likely avoids conventional negative feedback by phosphatases. Consistent with this idea, we provide evidence that the carboxy-terminal repeat of GRA24 is essential for binding to p38α and its subsequent autophosphorylation ([Fig. 6 B](#fig6){ref-type="fig"}). Furthermore, molecular modeling reveals that GRA24 repeat contains a p38α docking KIM motif that is phylogenetically related to those of the PTP tyrosine phosphatase family ([Fig. 6 D](#fig6){ref-type="fig"}). Collectively, these data suggest that GRA24 has evolved a structurally optimized KIM domain that might be able to compete accurately with the phosphatases for binding to MAPK.

*Toxoplasma*-induced p38α activation was initially reported as TAK1- and Myd88-independent and proposed to occur through an association with the scaffold protein TAB1 ([@bib29]). But---of note---first, TAB1 does not activate p38α after TNF exposure of fibroblasts derived from the MKK3-MKK6 double knockout mice ([@bib6]), and second, once bound to p38α, TAB1 prevents the p38α nuclear localization ([@bib32]) disproving the validity of this proposal. In contrast, our many complementary data allow us to highlight a major role for GRA24 as the shuttling and scaffolding protein that allows not only the p38α nuclear localization but also its autophosphorylation, at least in two distinct cell lineages---fibroblasts and macrophages---that *T. gondii* tachyzoites do subvert as host cells. Moreover, a contribution of parasite-derived tyrosine kinase is also very unlikely because bypassing the recourse to tachyzoites, through the ectopic expression of GRA24 in mammalian cells, is clearly sufficient to promote p38α autophosphorylation. It is noteworthy that *GRA24* has multiple alternative splice variants. Specifically, the presence of the exon E3b in the mRNA isoform 2 introduces a premature stop codon, leading to a protein variant devoid of the terminal repeats R1 and R2 ([Fig. 1 A](#fig1){ref-type="fig"}). In this fashion, the parasite might use alternative splicing to turn off GRA24-dependent p38α autophosphorylation under certain growth or developmental conditions, which remain to be discovered.

The ability of GRA24 to directly promote host p38α autophosphorylation places it as a potential regulator of the synthesis of growth factors and/or cytokines/chemokines and associated receptors, at least in macrophages once they are subverted as tachyzoite-hosting cells. Using microarray analysis, we showed that GRA24 controls, at the transcriptional level, an impressive network of genes encoding for cytokines/chemokines ([Fig. 8](#fig8){ref-type="fig"}), well beyond those associated previously with the secretion of GRA15 ([@bib26]; [@bib45]). Chief among the cytokines is the proinflammatory cytokine IL-12p40, with a 20-fold transcript excess that typifies a robust M1 profile in MØ hosting type II tachyzoites. As reported previously, IL-12 synthesis induction by *Toxoplasma*-infected MØ occurs at lower levels and with distinct kinetics relative to endotoxin stimulation; in brief, although IL-12 levels peaks within 6 h of LPS stimulation ([@bib29]), parasite-induced IL-12 is detected within a 24--40-h window after macrophage invasion ([Fig. 9 A](#fig9){ref-type="fig"} and [@bib29]). This timing is consistent with the kinetics of GRA24 secretion and the requisite for de novo synthesis of p38-activated transcription factors driving IL-12 synthesis. Of note, once macrophages are hosting tachyzoites, both IL-1β and IL-18 signaling use MyD88 as an adaptor, leading to NF-κB and MAPK activation and subsequent IL-12 production ([@bib1]). It is also noteworthy that IL-18 is approximately sixfold induced by GRA24 in MØ infected with type II strain ([Fig. 8 A](#fig8){ref-type="fig"}). It is therefore possible that autocrine production of IL-18 results in GRA24-mediated IL-12 release. Anyhow, the massive production of IL-12 induced by type II strains when tachyzoites start to proliferate is most likely controlled by the synergistic action of GRA15 and GRA24, which keep parasite numbers low, thus facilitating long-term parasitism. This is consistent with the observation that *GRA24* is one among the few polymorphic highly expressed genes that are under positive selection in *Toxoplasma* population ([@bib37]). We can also speculate that *GRA24* loss in *Neospora caninum* correlates with the inability of *Neospora* to properly modulate the host immune response, an argument which has been put forward earlier to explain why *Neospora* has a more limited host range than *Toxoplasma* ([@bib42]).

Besides triggering a strong Th1 response, GRA24 also significantly contributes to suppress M2 markers at the transcriptional level in MØ hosting type II tachyzoites, a situation which powers the M1 response. The repertoire of M2 genes that are down-regulated in a GRA24-dependent manner again significantly exceeds that of GRA15, with *Arg1* being distinctively ∼60-fold repressed by GRA24 ([@bib26]; [Fig. 8 B](#fig8){ref-type="fig"}). However, neither arginase-1 nor the mannose receptor type C (Mrc1/CD206) are induced at the protein level in Δ*gra24*-infected BMDMs (unpublished data), suggesting that the suppression of the GRA24-dependent transcriptional repression of M2 genes in type II strain is not sufficient to induce the production of the corresponding protein product, consistent with previous studies ([@bib7]; [@bib26]). Additionally, GRA24 is found to critically account for the typical increase at the protein level of four chemokines including MCP-1/CCL2 ([Fig. 8 A](#fig8){ref-type="fig"} and [Fig. 9 D](#fig9){ref-type="fig"}). Remarkably, in mice lacking MCP-1 or its receptor CCR2, no recruitment, in *T. gondii*--hosting tissues, of inflammatory Gr-1^+^ monocytes, is detectable, a situation which likely accounts for the sustained parasite burden and early host mortality ([@bib44]; [@bib12]). Consistent with these data, we show that mice infected with Δ*gra24* tachyzoites fail to control parasite numbers in the gut ([Fig. 9 E](#fig9){ref-type="fig"}), revealing a contributory role for GRA24 in resistance to acute toxoplasmosis, most likely through the regulation of cytokine expression and secretion including MCP-1.

GRA24 also significantly induces the secretion of CXCL10/IP-10 ([Fig. 8 A](#fig8){ref-type="fig"} and [Fig. 9 D](#fig9){ref-type="fig"}). This chemokine is required for preventing uncontrolled *T. gondii* tachyzoite burden ([@bib28]), and its depletion prevents T cell recruitment and effector function in mouse tissues where the tachyzoite to bradyzoite developmental transition is known to occur. In this regard, it was recently shown that the CXCL10/IP-10 chemokine enhances the ability of CD8^+^ T cells to control tachyzoite reexpansion in cyst-hosting mouse brains ([@bib22]). Collectively, these studies underscore the importance of GRA24 in orchestrating a cell response during *Toxoplasma* infections by promoting the induction of a selective set of chemokines, which contributes to the recruitment of inflammatory monocytes previously described as a first line of defense controlling intestinal pathogens, including *T. gondii* ([@bib12]).

Given that GRA24 was involved in nonprototypical direct p38α activation, we next sought to trace the factors that act downstream of this unusual signaling pathway. This led us to show that several transcription factors, including Egr-1 and c-Fos ([Fig. 10 A](#fig10){ref-type="fig"}), inhabit key downstream positions within this coordinated acute inflammatory process driven by tachyzoites nested within macrophage PV. Several factors are needed for full, regulated transactivation of the *Egr1* ([@bib51]) or *c-Fos* ([@bib39]) genes. As such, the mitogen- and stress-induced phosphorylation of CREB (CRE binding protein) at Ser133, especially by p38α, has been linked to the transcription of several immediate early genes, including c-fos, junB, and Egr-1 ([@bib51]; [@bib39]). In this regard, the *Toxoplasma* tachyzoite, in a GRA24-dependent fashion, positively affects the transcription of two CREB orthologs, i.e., CREB2/ATF2 and CREBL2 ([Fig. 10 A](#fig10){ref-type="fig"}), as well as CREB-dependent downstream genes (GEO accession no. [GSE38782](GSE38782)). We first thought that GRA24 might activate p38α, which in turn directly phosphorylates CREB-related factors in macrophages hosting tachyzoites. But this is apparently more complicated because *Toxoplasma* induces the phosphorylation of both CREB-Ser133 and ATF2-Thr-71 independently of GRA24 ([Fig. 4 D](#fig4){ref-type="fig"}). Therefore, GRA24 might act upstream in the pathway. It was previously shown that the phosphorylation of Ser 133 facilitates the ability of CREB to interact with CBP (CREB-binding protein) and its paralog p300, therefore leading to the transcription of CREB-responsive genes ([@bib27]). CBP and p300 possess an intrinsic acetylation activity and are thought to acetylate specific histone tails, thereby assuring relaxation of the chromatin environment ([@bib27]). As such, the sustained presence of GRA24-p38α in the nucleus of the tachyzoites-hosting macrophages might reflect the need for the complex to be embedded in the chromatin to operate in the vicinity of p38α MAPK-responsive genes. A GRA24-dependent response might alternatively be mediated through Egr-1 that physically and functionally interacts with CBP/p300 to modulate gene transcription ([@bib50]). Although interesting, this hypothesis deserves further investigation.

In conclusion, GRA24 extends the scope of the function of *T. gondii* DG proteins beyond their initial and dedicated role in PV formation and maturation. Moreover, the specific attributes of the GRA24-dependent p38α activation unveil a novel regulatory path for p38α-controlled transcriptional changes. This path not only shortcuts the canonical MAPK signaling cascade turned on in response to various stress-related stimuli and intracellular pathogens ([@bib14]; [@bib30]) but it also differs from the alternate p38 activation pathways described so far involving the scaffolding protein TAB1 or the T cell--restricted kinase ZAP-70 ([@bib6]; [@bib47]).

MATERIALS AND METHODS
=====================

### Parasites and host cells.

HFF primary cells, 293-TRex, and J774 cell lines were cultured in DMEM (Invitrogen) supplemented with 10% heat inactivated FBS (Invitrogen), 10 mM Hepes buffer, pH 7.2, 2 mM [l]{.smallcaps}-glutamine, and 50 µg/ml penicillin and streptomycin (Invitrogen). Cells were incubated at 37°C in 5% CO~2.~ BMDMs were obtained from female C57BL/6 mice. Bone marrow was isolated by flushing hind tibias and femurs using a 25-gauge needle followed by passages through an 18-gauge needle to disperse cell clamps. Cells were suspended in DMEM supplemented with 10% heat-inactivated FBS and 20 ng/ml recombinant M-CSF (Invitrogen), and incubated in a tissue culture-treated flask for 8--12 h. Then, nonadherent cells were harvested and transferred in 55 cm^2^ non--tissue culture--treated plates (Corning) at 4--6 × 10^6^ cells per plate and further incubated at 37°C, with 5% CO~2~ in humidified air. After 6 d, cells were washed with PBS to remove nonadherent cells, harvested by dislodging with a cell scraper in ice-cold PBS, and replated for the assay. This method yielded a highly pure population of F4/80^+^ macrophages by IFA. The *Toxoplasma* strains used in this study are listed in Table S1. All *T. gondii* strains were maintained in vitro by serial passage on monolayers of HFFs.

### Reagents.

Antibodies against HA (3F10; Roche), MIC2 (provided by D. Sibley, Washington University School of Medicine, St. Louis, MO), Toxofilin (provided by I. Tardieux, INSERM, U1016, Institut Cochin, Paris, France), GRA1 and GRA7 (provided by J.-F. Dubremetz, UMR 5235 Centre National de la Recherche Scientifique, Montpellier, France), p38 MAPK (Cell Signaling Technology), Phospho-p38 MAPK (Cell Signaling Technology), Phospho-c-Fos (Ser32; Cell Signaling Technology), H4 Acetylated (EMD Millipore), TgHDAC3 ([@bib4]), EGR1 (Cell Signaling Technology), and anti-TBP (Abcam) were used in the immunofluorescence assay and/or in Western blotting. Immunofluorescence secondary antibodies were coupled with Alexa Fluor 488 or Alexa Fluor 594 (Invitrogen). Secondary antibodies used in Western blotting were conjugated to alkaline phosphatase (Promega). The inhibitors SB203580, SP600125, and PD98059 were purchased from InvivoGen.

### Immunofluorescence microscopy.

Immunofluorescence assays were performed as described in [@bib4]. Cells grown on coverslips were washed in PBS and fixed for 20 min at room temperature with PBS containing 3% (vol/vol) formaldehyde. Fixed cells were permeabilized with PBS-0.1% Triton X-100 (vol/vol) for 10 min and blocked in PBS-3% BSA for 1 h at room temperature. Samples were incubated in PBS containing 3% BSA with the primary antibodies indicated in the figures, followed by the secondary antibodies coupled with Alexa Fluor 488 or Alexa Fluor 568 (Invitrogen) at a 1:1,000 dilution each in PBS--3% BSA. Nuclei of both host cells and parasites were stained for 10 min at room temperature with Hoechst 33258 at 2 µg/ml in PBS. After four washes in PBS, coverslips were mounted on a glass slide with Mowiol mounting medium. Images were acquired with a fluorescence microscope (Axioplan 2; Carl Zeiss).

### Plasmid constructs.

To construct the vector pLIC-*GRA24*-HF, the coding sequence of *GRA24* was amplified using primers LICF-117710_F and LICR-117710_R using RH genomic DNA as template. The resulting PCR product was cloned into the pLIC-HF-*dhfr* vector ([@bib5]) using the LIC cloning method previously reported ([@bib25]). The C-terminal truncated versions of *GRA24* were amplified and cloned in the aforementioned pLIC-HF-*dhfr* vector to generate pLIC-*GRA24*ΔR2-HF and pLIC-*GRA24*ΔR1/R2-HF. The pLIC-P~GRA24~-*GRA24*-HF was obtained by amplifying the promoter and coding region of *GRA24* (strain GT1, Chromosome VIII, position 664,928--671,201) with LICF--5′ region--117710_F2 and LICR-117710_R2 primers. The resulting PCR product was cloned in the aforementioned pLIC-HF-*dhfr* vector. To construct the mammalian expression vector pcDNA-*GRA24*-HF, the coding sequence of GRA24 (residues 25--542) was amplified from a poly(A)^+^ enriched RH cDNA library using pcDNA4-LIC-117710-HAFlag_F and pcDNA4-LIC-117710-HAFlag_R primers. The resulting PCR product was cloned by LIC into the pcDNA-LIC-HF plasmid ([@bib5]). Likewise, pcDNA4-FlagHA-LIC-117710_F and pcDNA4-FlagHA-LIC-117710_R primers were used to generate the plasmid pcDNA-HF-*GRA24* harboring an N-terminal HAFlag tag. The vector pDEST14 KO*GRA24* was generated to construct the deletion/insertion mutation of *GRA24* in *Toxoplasma* strains RH*ku80* (type I, [@bib25]) and Pru*ku80* (type II, [@bib15]). The Multisite Gateway Pro 3-fragment Recombination system was used to clone the *dhfr* cassette flanked by the 5′ and 3′ surrounding regions of *GRA24* coding sequence of RH genomic DNA. The 5′ flanking region of *GRA24* of RH strain was amplified using primers attB1-117710_F and attB4-117710_R, and was cloned into the plasmid pDONR221 P1-P4 (Invitrogen). The 3′ flanking region of *GRA24* was amplified using primers attB3-117710_F and attB2-117710_R, and was cloned into the plasmid pDONR221 P3-P2 (Invitrogen). The resulting vectors, pDONR221/5′*GRA24* and pDONR221/3′*GRA24*, respectively, were then recombined with pDONR221/DHFR ([@bib5]) into the destination vector pDEST14, yielding the pDEST14 KO*GRA24*. The vector pDEST14 KO*GRA15* was generated to construct the deletion/insertion mutation of *gra15* in *T. gondii* Pru*ku80* strain. The 5′ flanking region of *GRA15* of type II Pru strain was amplified using primers attB1-275470_F and attB4-275470_R, and was cloned into the plasmid pDONR221 P1-P4 (Invitrogen). The 3′ flanking region of *gra15* was amplified using primers attB3-275470_F and attB2-275470_R, and was cloned into the plasmid pDONR221 P3-P2 (Invitrogen). The resulting vectors, pDONR221/5′*gra15* and pDONR221/3′*gra15*, respectively, were then recombined with the pDONR221/DHFR ([@bib5]) into the destination vector pDEST14, yielding the pDEST14 KO*GRA15*.

### *Toxoplasma* transfection.

Vectors were transfected into RH*ku80* and Pru*ku80* parasites by electroporation. Electroporation was done in a 2-mm cuvette in a BTX ECM 630 (Harvard Apparatus) at 1,100 V, 25 Ω, and 25 μF. Stable integrants were selected in media with 1 µM pyrimethamine and cloned by limiting dilution.

### Endogenous gene tagging in *Toxoplasma*.

We used the RH*ku80* strain ([@bib25]) to endogenously tag *GRA24* in *Toxoplasma*. In brief, ∼20 µg of each DNA construct was linearized within the region of homology. Linearized vectors pLIC-*GRA24*-HF (BsiWI), pLIC-*GRA24*ΔR2-HF (BlpI), and pLIC-*GRA24*ΔR1/R2-HF (BlpI) were phenol-chloroform extracted and ethanol precipitated. Constructions were resuspended in TlowE buffer (10 mM Tris-HCl, pH 8.0, and 0.1 mM EDTA) for transfection. Stable recombinants were selected with pyrimethamine, single-cloned by limiting dilution, and verified by IFA. The resulting strains are RH*ku80 GRA24*-HF, RH*ku80 GRA24*ΔR2-HF, and RH*ku80 GRA24*ΔR1/R2-HF, respectively (Table S1).

### Generation of knockout and complementation.

To construct the deletion/insertion mutation of *GRA24* in type I (RH*ku80*) and type II (Pru*ku80*) strains of *Toxoplasma*, the plasmid pDEST14 KO*GRA24* was amplified by PCR using primers attB1-117710_F and attB2-117710_R. After sodium acetate/ethanol precipitation, DNA was resuspended in TlowE buffer (10 mM Tris-HCl, pH 8.0, and 0.1 mM EDTA) and ∼20 µg of PCR product was used for transfection. Recombinants were single-cell cloned by limiting dilution and verified by PCR analysis as follows. PCR with either a forward primer (5′ region--117710_F2) upstream of the 5′ flanking region used to generate the knockout construction and a reverse primer within the *dhfr* cassette (dhfr-KO-ol1_R) or a forward primer within the *dhfr* cassette (dhfr-KO-ol1_F) and a reverse primer (3′ region--117710_R1) downstream of the 3′ flanking region of *GRA24* confirmed a disruption in the *GRA24* locus. Further PCRs were performed to confirm the inability to amplify *GRA24* coding sequence using primers (pcDNA4-FlagHA-LIC-117710_F and pcDNA4-FlagHA-LIC-117710_R) in both type I and type II strains. The deletion/insertion mutation of *GRA15* in Pru*ku80* was constructed as described above with the plasmid pDEST14 KO*GRA15* amplified by PCR using primers attB1-275470_F and attB2-275470_R. Disruption in the *GRA15* locus was confirmed by PCR analysis with either a forward primer (5′ region--275470_F) upstream of the 5′ flanking region used to generate the knockout construction and a reverse primer within the *dhfr* cassette (dhfr-KO-ol1_R) or a forward primer within the *dhfr* cassette (dhfr-KO-ol1_F) and a reverse primer (3′ region--275470_R) downstream of the 3′ flanking region of *gra15*. To generate a complemented RH*ku80*Δ*gra24* strain, vector pLIC-P~GRA24~-*GRA24*-HF was co-electroporated with the pMiniHX at 1:10 ratio, followed by selection with mycophenolic acid and xanthine, and cloned by limiting dilution. The resulting strain is named RH*ku80* Δ*gra24*, *GRA24*^+^ (Table S1).

### 293-TRex transfection.

24 h before transfection, the cells were plated (80% confluency) in 6-well tissue culture dishes. 1 µg Flag--fusion protein--expressing plasmids and 0.1 µg puromycin selection plasmid were cotransfected into 293-TRex cells with Lipofectamine reagent (Invitrogen) according to the manufacturer's instructions. 72 h later, cells were diluted in the presence of 5 µg/ml puromycin (Sigma-Aldrich) for selection. Individual drug-resistant clones were expanded and tested for tetracycline-inducible gene expression.

### Chromatographic purification of GRA24-containing complexes.

Nuclear extracts from 293-TRex cells stably expressing Flag-tagged protein were incubated with anti-FLAG M2 affinity gel (Sigma-Aldrich) for 1 h at 4°C. Beads were washed with 10-column volumes of BC500 buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.1% NP-40, 0.5 mM PMSF, and 1 µg ml^−1^ each of aprotinin, leupeptin, and pepstatin). Bound peptides were eluted stepwise with 250 µg ml^−1^ FLAG peptide (Sigma-Aldrich) diluted in BC100 buffer. For size-exclusion chromatography, protein eluates were loaded onto a Superose 6 HR 10/30 column equilibrated with BC500. Flow rate was fixed at 0.35 ml/min, and 0.5-ml fractions were collected.

### Mass spectrometry and peptide sequencing.

Protein bands were excised from colloidal blue--stained gels (Invitrogen), treated with DTT and iodoacetamide to alkylate the cysteines, and then immediately subjected to in-gel tryptic digestion. Peptides were extracted with 5% vol/vol formic acid solution and acetonitrile, and injected into an Ultimate 3000 (Dionex) nanoLC system that was directly coupled to a LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific). MS and MS/MS data were acquired using Xcalibur (Thermo Fischer Scientific) and processed automatically using Mascot Daemon software (Matrix Science). Tandem mass spectra were searched against a compiled *T. gondii* database using the MASCOT program (Matrix Sciences).

### Cell fractionation.

For cytosolic and nuclear fractionation analysis, cells were washed in ice-cold PBS and harvested using a cell scraper. After centrifugation, cells were resuspended in buffer D (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl~2~, 0.34 M Sucrose, 10% Glycerol, 1 mM DTT, and 1× Roche protease inhibitor cocktail) and lysed for 8 min with Triton X-100 at a final concentration of 0.1%. Cell lysates were centrifuged at 1,300 *g* for 5 min and the supernatant containing the cytosolic fraction was collected. The pellet, containing the nuclear fraction, was washed once in buffer D and resuspended in cell extraction buffer (Invitrogen) for protein extraction. The supernatant and pellet fractions were clarified by centrifugation at 20,000 *g* for 10 min at 4°C. Supernatants were mixed with protein sample buffer (Invitrogen) for Western blot analysis.

### Western blot.

Proteins were separated by SDS-PAGE, transferred to a polyvinylidene fluoride membrane (Immobilon-P; Millipore) by liquid transfer and Western blots were probed using appropriate primary antibodies followed by phosphatase-conjugated goat secondary antibodies (Promega). Signals were detected using NBT-BCIP (Amresco).

### In vitro cytokine ELISA.

C57BL/6 BMDMs were seeded (4 × 10^5^ per well) in 96-well plates and left to adhere overnight at 37°C in 5% CO~2~. Cells were infected with freshly lysed *T. gondii* tachyzoites at MOI = 3, and supernatants (200 µl) were collected 24 h after infection and stored at −20°C if necessary. IL-12p40 levels were determined using a commercially available ELISA kit (Mouse IL-12 p40 ELISA kit; Thermo Fisher Scientific) according to the manufacturer's instructions.

### Chemokine array.

For qualitative determination of the kinds of chemokines secreted by infected BMDM, chemokine Ab arrays were performed with culture supernatant. Macrophages were left uninfected or infected with Pru*ku80* or Pru*ku80 Δgra24* strain parasites at an MOI of 3. Culture supernatant was harvested after 24 h and used in mouse chemokine Ab arrays according to the manufacturer's instructions (R&D Systems). In brief, supernatant was incubated with an array membrane on which 25 different mouse chemokine Abs were bound. The membrane was then incubated with a mixture of biotinylated anti-chemokine Abs followed by HRP-conjugated streptavidin. Detection was by chemiluminescence reagents provided by the manufacturer.

### Quantitative real-time RT-PCR.

Total RNA was isolated from HFFs or BMDM infected with Pru or RH strains using TRIzol reagent (Invitrogen). cDNA was synthesized with random hexamers by using the High Capacity RNA-to-cDNA kit (Applied Biosystems). Samples were analyzed by real-time quantitative PCR for *IL-12b*, *IFN-γ*, *CD70*, and *CD200* using TaqMan Gene Expression Master Mix (Applied Biosystems) according to the manufacturer's instructions. *β2-microglobulin* was used as an internal control gene.

### Structural studies.

Based on sequence similarities, we have generated a GRA24-KIM 16-aa (GLLERRGVSELPPLYI) model using the HePTP phosphatase KIM domain (RLQERRGSNVALMLDV) from structure 2GPH ([@bib56]) as a template, with appropriate residue mutations. The conformation of the side-chains and orientation of the main-chain for N- and C-terminal regions of peptides were modeled based on the bound peptide conformations in crystal structures of ERK2-pepHePTPm (2GPH) and p38-pepMEF2 (1LEW) peptide complexes, respectively. Similar work has been done with GRA24-KIM2(519--534), i.e., with an R instead of Y, with no significant differences. A p38--GRA24-KIM binary complex was then prepared using Coot modeling software ([@bib13]). The structure of p38, isolated from the p38--pepMEF2 complex (PDB accession no. [1LEW](1LEW); [@bib8]) was used as template for p38--GRA24-KIM docking and energy minimization calculations. The p38--GRA24-KIM complex was then subjected to energy minimization cycles under the MacroModel software (Schrödinger, LLC) using the OPLS-2005 (Optimized Potential for Liquid Simulations) force field and water as a solvent with constant dielectric value of 1. All the atoms in protein as well as peptide models were allowed to move freely. Energy minimization of structures were completed via the PRCG (Polak-Ribiere Conjugate Gradient) energy minimization procedure at 10,000 iterations and performed to a convergence threshold of 0.02 kJ mol^−1^-Å).

### Microarray hybridization and data analysis.

BMDMs were plated at 8--10 × 10^6^ cells per 55 cm^2^ plate, infected (MOI = 3) for 18 h with RH*ku80*, RH*ku80* Δ*gra24*, Pru*ku80*, and Pru*ku80* Δ*gra24*. RNA was isolated using TRIzol reagent (Invitrogen), followed by phenol/chloroform/isoamyl extraction. Transcripts were obtained from three biological replicates each. RNA Labeling and Array Hybridization of BMDM/RH*ku80* and BMDM/Pru*ku80* experiments were done by ArrayStar as follows: sample labeling and array hybridization were performed according to the One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology). In brief, total RNA from each sample was linearly amplified and labeled with Cy3-UTP. The labeled cRNAs were purified by the RNeasy Mini kit (QIAGEN). The concentration and specific activity of the labeled cRNAs (pmol Cy3/µg cRNA) were measured by NanoDrop ND-1000. 1 µg of each labeled cRNA was fragmented by adding 11 µl of 10× blocking agent and 2.2 µl of 25× fragmentation buffer, the mixture was heated at 60°C for 30 min, and finally, 55 µl of 2× GE Hybridization buffer was added to dilute the labeled cRNA. 100 µl of hybridization solution was dispensed into the gasket slide and assembled to the gene expression microarray slide. The Mouse 4× 44K Gene Expression Array was manufactured by Agilent Technologies. The slides were incubated for 17 h at 65°C in a hybridization oven (Agilent Technologies). The hybridized arrays were washed, fixed, and scanned using the DNA Microarray Scanner (part number G2505B; Agilent Technologies). Microarray data analysis of acquired array images was performed using the Feature Extraction software (version 10.7.3.1; Agilent Technologies). Quantile normalization and subsequent data processing were performed using the GeneSpring GX software package (version 11.5.1; Agilent Technologies). After quantile normalization of the raw data, genes in which at least six out of nine samples have flags in Detected or Not Detected (All Targets Value) were chosen for further data analysis. Differentially expressed genes with statistical significance were identified through Volcano Plot filtering between two groups (WT versus *GRA24* mutant) of compared arrays. The thresholds are fold change ≥ 2.0, p-value ≤ 0.05. GO analysis and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis were performed using the DAVID Bioinformatics Resources. Microarray data has been uploaded to GEO Datasets under accession no. [GSE38782](GSE38782).

### Online supplemental material.

Fig. S1 shows a schematic representation of the strategy and analysis of *GRA24* knockout. Table S1 provides a list of the vectors and the oligonucleotides used in this study. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20130103/DC1>.
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